← 프로그램 목록
Phase 2Active

Valacyclovir

GlaxoSmithKline

비교

Valacyclovir(GlaxoSmithKline)은 Metastatic Non-small Cell Lung Cancer 표적 치료제로, Metastatic Non-small Cell Lung Cancer; Metastatic Triple-negative Breast Cancer 영역에서 개발·상용화 중입니다. 작용기전: of AXX-18 was found to be similar to that of oleanolic acid, except that AXX-18 could act on both the UL8 and UL52 proteins of the uncoupling helicase-primase enzyme, whereas olean. Phase 2에서 효능·안전성 신호를 검증 중입니다. 대표 임상 효능: ORR 20% (ClinicalTrials.gov NCT00492050). PK: t½ 14 h. 차별점: unique case of valacyclovir-induced psychosis in a patient with pre-existing renal failure, emphasizing the importance of cons.

출처: ClinicalTrials.gov · PubMed · openFDA최근 동기화됨

개요

임상 2026년 7월 12일 (1일 전)PK/독성 2026년 7월 12일 (1일 전)

Metastatic Non-small Cell Lung Cancer

Metastatic Non-small Cell Lung Cancer; Metastatic Triple-negative Breast Cancer

Active

Technology

ADCS-ADL) Scale score; LSM change in the 18F-florbetapir amyloi

adenoviral vectors expressing HSV1-TK (Ad-hCMV-TK) and Flt3L (Ad-hCMV-Flt3L) in patients w

unique case of valacyclovir-induced psychosis in a patient with pre-existing renal failure, emphasizing the importance of cons

Mechanism of Action

of AXX-18 was found to be similar to that of oleanolic acid, except that AXX-18 could act on both the UL8 and UL52 proteins of the uncoupling helicase-primase enzyme, whereas oleanolic acid could only act on the UL8 pro

immune-mediated cytotoxicity in patients with prostate cancer

apoptosis, colony formation, metastasis, and cell cycle of cancer cells

biomarkers for AD, a positive serum antibody test (IgG or IgM) for HSV-1 or HSV-2, and a Mini-Mental State Ex

임상시험 & 결과

차트 로드 중…

임상 한눈에 보기

  • 58건의 ClinicalTrials.gov 임상 기록
  • Phase·Status 요약은 enrollment 상위 표본 기준입니다
  • 임상시험 탭에서 enrollment 상위 목록을 불러올 수 있습니다
  • Phase: Phase 3 · N/A · Phase 4 · Phase 2
  • Status: Completed · Unknown status · Terminated
  • 주요 endpoint: Investigator-assessed Time to Healing of All Non-aborted Genital Herpes Lesions · Percentage of Participants With Aborted Genital Herpes Lesions · Investigator-assessed Time to Healing of All (Non-aborted and Aborted) Genital Herpes Lesions · Time to Resolution of Symptoms Associated With Recurrent Genital Herpes · Number of Patients With a Second Recurrence of Genital Herpes
  • 등록된 결과: ORR 20%
  • 핵심: The main goal of this clinical research study is to learn if Velcade ® (bortezomib) given with rituximab can help to con…

임상시험이 많습니다. 임상시험 탭에서 Phase/Status 필터·검색을 사용하세요.

수집된 임상 필드(phase, status, endpoint 등) 기반 자동 요약입니다.

참고문헌

자주 묻는 질문

Valacyclovir은 어떤 치료제인가요?
Valacyclovir(GlaxoSmithKline)은 Metastatic Non-small Cell Lung Cancer 표적 항체로, Metastatic Non-small Cell Lung Cancer; Metastatic Triple-negative Breast Cancer 영역에서 개발·상용화 중입니다. 데이터는 바이오모아 (BioMoa)에서 ClinicalTrials.gov·openFDA·PubMed 기반으로 정리합니다.
Valacyclovir의 임상 단계는?
Valacyclovir의 현재 단계는 Phase 2입니다.
비슷한 프로그램과 어떻게 비교하나요?
바이오모아 (BioMoa) 비교 페이지에서 PK/PD, 독성, 임상 효능 지표를 나란히 볼 수 있습니다. 동일 타깃·모달리티 프리셋을 함께 참고하세요.